Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602561 · ClinicalTrials.gov registry record · NA
Effects of HMB Supplementation on Recovery Following ACL Surgery
A NA study, sponsored by Metabolic Technologies.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02602561 is a NA study that has completed, run by Metabolic Technologies. The registered enrollment target is 4 participants.
The verdict
NCT02602561, a NA study, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The anterior cruciate ligament (ACL) is a primary stabilizer of the knee, and thus when ACL injury occurs participation in physical activity is compromised. Reconstructive surgery is often necessary to repair the damage which is then followed by a regimen of physical therapy in order to regain full activity. Nutritional intervention after the surgery could help the patient maintain muscle mass during recovery, thus allowing for a quicker return to normal activity.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT HMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02602561
The ClinicalTrials.gov registry entry for NCT02602561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metabolic Technologies, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02602561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02602561 about?
NCT02602561 is a clinical study titled "Effects of HMB Supplementation on Recovery Following ACL Surgery". The anterior cruciate ligament (ACL) is a primary stabilizer of the knee, and thus when ACL injury occurs participation in physical activity is compromised. Reconstructive surgery is often necessary to repair the damage which is then followed by a regimen of physical therapy in order to regain full ...
What is the current status of trial NCT02602561?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2015-11. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02602561?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), HMB (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02602561?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.